JNK signalling in cancer: in need of new, smarter therapeutic targets
The JNKs are master protein kinases that regulate many physiological processes, including
inflammatory responses, morphogenesis, cell proliferation, differentiation, survival and …
inflammatory responses, morphogenesis, cell proliferation, differentiation, survival and …
[HTML][HTML] Map kinase signaling pathways and hematologic malignancies
LC Platanias - Blood, 2003 - Elsevier
Mitogen-activated protein (Map) kinases are widely expressed serine-threonine kinases that
mediate important regulatory signals in the cell. Three major groups of Map kinases exist …
mediate important regulatory signals in the cell. Three major groups of Map kinases exist …
Choosing the right cell line for acute myeloid leukemia (AML) research
R Skopek, M Palusińska, K Kaczor-Keller… - International journal of …, 2023 - mdpi.com
Immortalized cell lines are widely used in vitro tools in oncology and hematology research.
While these cell lines represent artificial systems and may accumulate genetic aberrations …
While these cell lines represent artificial systems and may accumulate genetic aberrations …
Activation of the JNK signaling pathway: breaking the brake on apoptosis
A Lin - Bioessays, 2003 - Wiley Online Library
The JNK signaling pathway is involved in regulation of many cellular events, including
growth control, transformation and programmed cell death (apoptosis). The role of JNK …
growth control, transformation and programmed cell death (apoptosis). The role of JNK …
MAPK signaling pathways in the regulation of hematopoiesis
CR Geest, PJ Coffer - Journal of leukocyte biology, 2009 - academic.oup.com
Relevance of mitogen-activated protein kinases ERK, JNK, and p38 in the regulation of
myeloid differentiation. The MAPKs are a family of serine/threonine kinases that play an …
myeloid differentiation. The MAPKs are a family of serine/threonine kinases that play an …
Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized …
LD Cripe, H Uno, EM Paietta, MR Litzow… - Blood, The Journal …, 2010 - ashpublications.org
Zosuquidar, which modulates P-glycoprotein (P-gp) with minimal delay of anthracycline
clearance, may reverse P-gp–mediated resistance in acute myeloid leukemia without …
clearance, may reverse P-gp–mediated resistance in acute myeloid leukemia without …
Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1)
É Bakos, L Homolya - Pflügers Archiv-European Journal of Physiology, 2007 - Springer
Abstract MRP1 (ABCC1) is a peculiar member of the ABC transporter superfamily for several
aspects. This protein has an unusually broad substrate specificity and is capable of …
aspects. This protein has an unusually broad substrate specificity and is capable of …
Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies
D Mahadevan, AF List - Blood, 2004 - ashpublications.org
Abstract The multidrug resistance-1 (MDR1) gene product, P-glycoprotein (P-gp), and the
multidrug resistance–related proteins (MRPs) are members of the adenosine triphosphate …
multidrug resistance–related proteins (MRPs) are members of the adenosine triphosphate …
The activation of c-Jun NH2-terminal kinase (JNK) by DNA-damaging agents serves to promote drug resistance via activating transcription factor 2 (ATF2)-dependent …
J Hayakawa, C Depatie, M Ohmichi… - Journal of Biological …, 2003 - ASBMB
The activating transcription factor 2 (ATF2) is a member of the ATF/cAMP-response element-
binding protein family of basic-leucine zipper proteins involved in cellular stress response …
binding protein family of basic-leucine zipper proteins involved in cellular stress response …
Btk protein kinase inhibitors
NJ Dewdney, RK Kondru, Y Lou, M Soth… - US Patent …, 2011 - Google Patents
WO WO 2006/053121 A2 5, 2006 WO WO 2006/053121 A3 5, 2006 WO WO 2006/076592
A1 T 2006 WO WO 2006/0990.75 A2 9, 2006 WO WO 2006/0990.75 A3 9, 2006 WO WO …
A1 T 2006 WO WO 2006/0990.75 A2 9, 2006 WO WO 2006/0990.75 A3 9, 2006 WO WO …